Publication | Closed Access

Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC)

OncologyErlotinib PharmacokineticsMedicineMetronomic TherapyBronchial NeoplasmClinical OutcomesPharmacotherapyCancer TreatmentPharmacologyRadiation OncologyCutaneous ToxicityLung CancerHealth Sciences